Zhejiang Jiuzhou Pharmaceutical (603456.SH) plans to repurchase company shares worth 200 million to 400 million yuan.
Jiuzhou Pharmaceutical (603456.SH) announced that the company plans to repurchase its own shares through centralized competitive trading with its own funds. The amount of the repurchase shall not be less than 200 million yuan, and not more than 400 million yuan, with the repurchase price not exceeding 20 yuan per share. The repurchased shares will be partly used for the implementation of a stock incentive plan or employee stock ownership plan, and partly used for canceling and reducing the registered capital.
Zhejiang Jiuzhou Pharmaceutical (603456.SH) announced that the company plans to repurchase its own shares through centralized bidding trading with its own funds. The amount of shares to be repurchased will not be less than 200 million yuan and not more than 400 million yuan, and the repurchase price will not exceed 20 yuan per share. The repurchased shares will be partially used for future implementation of equity incentive plans or employee stock ownership plans, and partially used for cancellation and reduction of registered capital.
Related Articles
Luxin Venture Capital Group (600783.SH) plans to list and transfer 14.46% equity of Bi'an Power with a listing price of 56.0079 million yuan.
Shanghai Sanmao Enterprise (600689.SH) plans to transfer its 6% equity stake in Shuanglong Company through listing.
Changzhou Xingyu Automotive Lighting Systems (601799.SH) plans to launch an employee stock ownership plan in 2026.
Luxin Venture Capital Group (600783.SH) plans to list and transfer 14.46% equity of Bi'an Power with a listing price of 56.0079 million yuan.
Shanghai Sanmao Enterprise (600689.SH) plans to transfer its 6% equity stake in Shuanglong Company through listing.
Changzhou Xingyu Automotive Lighting Systems (601799.SH) plans to launch an employee stock ownership plan in 2026.
